Cheshire and Warrington set to benefit from £14.2m investment to support Higher Technical Skills Abigail Barker13 February 2023
Industry-First Cancer Screening Technology Boosted by Biomedical Grant Funding Daniella McCarron17 January 2023
Alchemab Therapeutics and Medicines Discovery Catapult Awarded £1.7 Million Grant From Innovate UK to Accelerate Development of Disease-Modifying Therapy for Huntington’s Disease Abigail Barker16 December 2022
Immundnz publishes article on human immune assay in peer reviewed journal Abigail Barker14 December 2022
Claritas Solutions expands to Alderley Park as it sets up North West team Abigail Barker7 December 2022
Infex enters clinic with lead anti-virulence candidate RESP-X for Pseudomonas aeruginosa Daniella McCarron21 November 2022
Stream Bio launches LINKBRIGHT™ rapid conjugation kits through Sigma-Aldrich Abigail Barker10 November 2022
Medicines Discovery Catapult and Xerion Healthcare Secure Funding for Innovative Brain Tumour Treatment Daniella McCarron3 November 2022
Medicines Discovery Catapult Appoints International Entrepreneur to Bolster Commercial Expertise Daniella McCarron26 October 2022
Leading game art studio Airship Interactive set to move to Alderley Park with 100+ new jobs planned Abigail Barker4 October 2022
LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts Abigail Barker28 September 2022
Plans Submitted for Ambitious New Life Science and Tech Developments at Alderley Park Daniella McCarron7 September 2022
Global Expansion: Psychiatry Consortium Welcomes New International Partner Daniella McCarron25 August 2022
